SEC Form 3 · accession 0000899243-18-011664
PROVECTUS BIOPHARMACEUTICALS, INC. · PVCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward Pershing
Director
Period of report
Apr 27, 2018
Accepted (ET)
May 7, 2018 · 5:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000315545
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 2,820,630 | D | ||
| Common Stock | holding | — | — | — | 77,100 | I | By spouse | |
| Common Stock | holding | — | — | — | 3,750 | I | As custodian for grandchild | |
| Common StockF1 | holding | — | — | — | 81,500 | I | By Mr. P's Foundation | |
| Common StockF1 | holding | — | — | — | 550,000 | I | By Perkins Place |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Warrants (right to buy)F2 | $0.85 | holding | — | — | — | — | Jun 19, 2020 | Common Stock | 705,000 | — | D |
| Common Stock Warrants (right to buy)F2 | $0.85 | holding | — | — | — | — | Jun 19, 2020 | Common Stock | 27,500 | — | I |
Explanation of responses
- F1The Reporting Person hereby disclaims ownership of these securities in excess of his pecuniary interest therein.
- F2The common stock warrants are exercisable currently.
Remarks
Exhibit 24.1-Power of Attorney